ACETAMINOPHEN, ASPIRIN, CAFFEINE

ACETAMINOPHEN, ASPIRIN, CAFFEINE was reported 224 times

ACETAMINOPHEN, ASPIRIN, CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BIOPSY THYROID GLAND ABNORMAL 1 0.0400
1 OESOPHAGEAL MUCOSAL DISSECTION 1 0.0256
2 STRAWBERRY TONGUE 1 0.0189
3 URINARY SEDIMENT 1 0.0172
4 LYMPHATIC OBSTRUCTION 1 0.0116
5 SLEEP INERTIA 1 0.0103
6 LITHIASIS 2 0.0066
7 EXPOSURE TO TOXIC AGENT 20 0.0062
8 UPPER RESPIRATORY FUNGAL INFECTION 1 0.0053
9 EXPOSURE TO UNSPECIFIED AGENT 1 0.0051
10 CRANIOFACIAL DEFORMITY 1 0.0043
11 ANORECTAL INFECTION 1 0.0040
12 HEPATIC VEIN THROMBOSIS 1 0.0032
13 NSAID EXACERBATED RESPIRATORY DISEASE 1 0.0026
14 OESOPHAGEAL INJURY 1 0.0026
15 HOUSEBOUND 1 0.0025
16 BONE FISSURE 1 0.0024
17 INFUSION SITE SCAR 1 0.0023
18 BODY HEIGHT INCREASED 1 0.0020
19 ORAL LICHEN PLANUS 1 0.0020
20 HYPOAESTHESIA EYE 1 0.0017
21 RECTAL ADENOCARCINOMA 1 0.0017
22 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
23 DELIVERY 1 0.0015
24 TRANSIENT GLOBAL AMNESIA 1 0.0014
25 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
26 PYLORIC STENOSIS 1 0.0012
27 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
28 SALIVA ALTERED 1 0.0011
29 METAMORPHOPSIA 2 0.0011
30 PRODUCT APPEARANCE CONFUSION 1 0.0011
31 BIOPSY 1 0.0011
32 EXPIRED PRODUCT ADMINISTERED 35 0.0011
33 PRODUCT AFTER TASTE 1 0.0010
34 HYPERVIGILANCE 1 0.0010
35 PRODUCT COMMINGLING 1 0.0009
36 LUMBAR RADICULOPATHY 1 0.0009
37 ORAL MUCOSA EROSION 1 0.0008
38 OBSTRUCTION GASTRIC 1 0.0008
39 LIP BLISTER 2 0.0007
40 CORNEAL OPACITY 1 0.0007
41 GENITAL RASH 1 0.0007
42 HORDEOLUM 3 0.0007
43 CONJUNCTIVITIS ALLERGIC 1 0.0007
44 COSTOCHONDRITIS 1 0.0006
45 LAZINESS 1 0.0006
46 INFUSION SITE DISCHARGE 1 0.0006
47 GLOSSITIS 2 0.0006
48 UNDERWEIGHT 1 0.0005
49 PRODUCT ODOUR ABNORMAL 5 0.0005
50 EAR SWELLING 1 0.0005
51 ANGINA UNSTABLE 3 0.0005
52 REACTION TO DRUG EXCIPIENTS 1 0.0005
53 CORNEAL DISORDER 1 0.0005
54 LIMB MASS 1 0.0005
55 PRODUCT LABEL ISSUE 3 0.0004
56 KOUNIS SYNDROME 1 0.0004
57 PERIARTHRITIS 1 0.0004
58 REACTION TO EXCIPIENT 1 0.0004
59 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
60 DISCOURAGEMENT 1 0.0004
61 PRURITUS GENITAL 1 0.0004
62 PAINFUL RESPIRATION 1 0.0004
63 PRODUCT PACKAGING CONFUSION 1 0.0004
64 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
65 DEVICE INFUSION ISSUE 1 0.0004
66 HEPATIC ENZYME ABNORMAL 2 0.0004
67 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
68 HAEMORRHAGE URINARY TRACT 1 0.0004
69 MENOPAUSE 1 0.0004
70 RHEUMATOID NODULE 1 0.0004
71 CEREBRAL THROMBOSIS 1 0.0004
72 JOINT LOCK 1 0.0004
73 FIBULA FRACTURE 1 0.0003
74 PLATELET COUNT ABNORMAL 2 0.0003
75 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
76 INFUSION SITE HAEMORRHAGE 1 0.0003
77 PRODUCT FORMULATION ISSUE 2 0.0003
78 EXPOSURE DURING BREAST FEEDING 1 0.0003
79 PEPTIC ULCER 1 0.0003
80 WOUND COMPLICATION 1 0.0003
81 MICTURITION DISORDER 1 0.0003
82 UNDERDOSE 21 0.0003
83 THROMBOPHLEBITIS 1 0.0003
84 SKIN WEEPING 1 0.0003
85 TONGUE DISORDER 2 0.0003
86 SPONDYLITIS 1 0.0003
87 DEVICE KINK 1 0.0003
88 ASTHMATIC CRISIS 1 0.0003
89 FOOD INTOLERANCE 1 0.0003
90 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
91 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
92 BLEPHARITIS 1 0.0002
93 TRIGEMINAL NEURALGIA 1 0.0002
94 SECRETION DISCHARGE 3 0.0002
95 ONYCHOMADESIS 1 0.0002
96 TONGUE DISCOMFORT 1 0.0002
97 PRODUCT DISPENSING ISSUE 1 0.0002
98 TEARFULNESS 1 0.0002
99 HEPATIC LESION 1 0.0002
100 WRONG DRUG ADMINISTERED 2 0.0002
101 URINARY TRACT DISORDER 1 0.0002
102 PRODUCT TASTE ABNORMAL 3 0.0002
103 HAEMOGLOBIN INCREASED 1 0.0002
104 EXOSTOSIS 2 0.0002
105 EAR DISORDER 1 0.0002
106 SYNOVIAL CYST 1 0.0002
107 UMBILICAL HERNIA 1 0.0002
108 BLOOD PROLACTIN INCREASED 1 0.0002
109 SPINAL DISORDER 2 0.0002
110 GESTATIONAL DIABETES 1 0.0002
111 MEDICATION RESIDUE PRESENT 1 0.0002
112 STILLBIRTH 1 0.0002
113 FINGER DEFORMITY 1 0.0002
114 MUCOUS STOOLS 1 0.0002
115 FOETAL DEATH 1 0.0002
116 TONSILLITIS 1 0.0002
117 SCRATCH 2 0.0002
118 ANORECTAL DISCOMFORT 1 0.0002
119 BODY HEIGHT DECREASED 2 0.0002
120 NORMAL NEWBORN 1 0.0002
121 JAW DISORDER 1 0.0002
122 HEART RATE ABNORMAL 1 0.0002
123 PERIORBITAL SWELLING 1 0.0002
124 HYPERVENTILATION 1 0.0002
125 PRODUCT LABEL CONFUSION 1 0.0002
126 DYSSTASIA 5 0.0002
127 SPINAL PAIN 2 0.0002
128 COLD SWEAT 3 0.0002
129 URINE ODOUR ABNORMAL 1 0.0002
130 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
131 TENSION 1 0.0002
132 INFUSION SITE EXTRAVASATION 1 0.0002
133 SWELLING OF EYELID 1 0.0002
134 INFUSION SITE SWELLING 1 0.0002
135 BLOOD URINE PRESENT 3 0.0002
136 GASTRIC ULCER 3 0.0002
137 NODULE 2 0.0002
138 POLYP 1 0.0002
139 TERMINAL STATE 1 0.0001
140 BRONCHIECTASIS 1 0.0001
141 POSTOPERATIVE WOUND INFECTION 1 0.0001
142 JOINT EFFUSION 1 0.0001
143 CARPAL TUNNEL SYNDROME 2 0.0001
144 DEFAECATION URGENCY 1 0.0001
145 PAPULE 1 0.0001
146 DUODENAL ULCER 1 0.0001
147 HAND FRACTURE 1 0.0001
148 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
149 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
150 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
151 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
152 SKIN HAEMORRHAGE 2 0.0001
153 PRODUCT AVAILABILITY ISSUE 3 0.0001
154 DRUG DISPENSING ERROR 2 0.0001
155 INSURANCE ISSUE 2 0.0001
156 ATRIOVENTRICULAR BLOCK 1 0.0001
157 CONCUSSION 1 0.0001
158 FURUNCLE 1 0.0001
159 NASAL DISCOMFORT 1 0.0001
160 FIBROMYALGIA 3 0.0001
161 ASPHYXIA 1 0.0001
162 HAIR DISORDER 1 0.0001
163 ACUTE CORONARY SYNDROME 1 0.0001
164 SENSATION OF FOREIGN BODY 1 0.0001
165 INFUSION SITE ERYTHEMA 1 0.0001
166 PSEUDOMONAS INFECTION 1 0.0001
167 INFLAMMATION 6 0.0001
168 MYOPATHY 1 0.0001
169 SKIN SWELLING 1 0.0001
170 SPINAL OSTEOARTHRITIS 1 0.0001
171 GRIP STRENGTH DECREASED 1 0.0001
172 GASTROENTERITIS VIRAL 2 0.0001
173 OROPHARYNGEAL DISCOMFORT 1 0.0001
174 LIP DRY 1 0.0001
175 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
176 COMPLETED SUICIDE 9 0.0001
177 INFLUENZA 12 0.0001
178 ERYTHEMA MULTIFORME 1 0.0001
179 APPENDICITIS 1 0.0001
180 PHOTOPHOBIA 2 0.0001
181 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
182 FEELING JITTERY 2 0.0001
183 HAEMORRHOIDS 2 0.0001
184 HEPATOMEGALY 1 0.0001
185 HYPOTONIA 1 0.0001
186 OVARIAN CYST 1 0.0001
187 FEEDING DISORDER 2 0.0001
188 DRY THROAT 1 0.0001
189 EUPHORIC MOOD 1 0.0001
190 EAR DISCOMFORT 1 0.0001
191 RENAL PAIN 1 0.0001
192 JOINT INJURY 2 0.0001
193 HEREDITARY ANGIOEDEMA 1 0.0001
194 POOR QUALITY SLEEP 2 0.0001
195 PHARYNGITIS STREPTOCOCCAL 1 0.0001
196 BACK INJURY 1 0.0001
197 WOUND INFECTION 1 0.0001
198 VIRAL INFECTION 3 0.0001
199 THROAT IRRITATION 4 0.0001
200 NEOPLASM 1 0.0001
201 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
202 MADAROSIS 1 0.0001
203 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
204 DRUG EFFECT INCOMPLETE 3 0.0001
205 SPINAL OPERATION 1 0.0001
206 HAIR COLOUR CHANGES 1 0.0001
207 POISONING 1 0.0001
208 DERMATITIS ALLERGIC 1 0.0001
209 PRODUCT COMPLAINT 2 0.0001
210 INTRAOCULAR PRESSURE INCREASED 1 0.0001
211 ILLNESS 8 0.0001
212 INFUSION SITE PAIN 1 0.0001
213 HIATUS HERNIA 1 0.0001
214 PLATELET COUNT INCREASED 1 0.0001
215 BEDRIDDEN 1 0.0001
216 ANKYLOSING SPONDYLITIS 1 0.0001
217 TOOTH INFECTION 1 0.0001
218 HAIR TEXTURE ABNORMAL 1 0.0001
219 JOINT RANGE OF MOTION DECREASED 1 0.0001
220 INCORRECT DOSE ADMINISTERED 17 0.0001
221 DRUG EFFECT DECREASED 4 0.0001
222 EXTRA DOSE ADMINISTERED 3 0.0001
223 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
224 UVEITIS 1 0.0001
225 GINGIVAL BLEEDING 1 0.0001
226 TREATMENT NONCOMPLIANCE 4 0.0001
227 ORAL DISCOMFORT 1 0.0001
228 MASS 1 0.0001
229 MOBILITY DECREASED 5 0.0001
230 IMPAIRED QUALITY OF LIFE 1 0.0001
231 PARAESTHESIA ORAL 1 0.0001
232 INJECTION SITE HAEMATOMA 1 0.0001
233 DYSPHONIA 4 0.0001
234 CARDIOMYOPATHY 1 0.0001
235 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
236 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
237 STOMATITIS 4 0.0001
238 ABDOMINAL DISCOMFORT 11 0.0001
239 DRUG ADMINISTRATION ERROR 2 0.0001
240 PRODUCT USE COMPLAINT 1 0.0001
241 ABDOMINAL PAIN UPPER 13 0.0001
242 RESPIRATORY TRACT CONGESTION 1 0.0001
243 MULTIPLE SCLEROSIS 3 0.0001
244 SWELLING FACE 4 0.0001
245 GAIT INABILITY 2 0.0001
246 CELLULITIS 3 0.0001
247 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
248 SCAR 1 0.0001
249 MUSCULOSKELETAL DISCOMFORT 1 0.0001
250 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
251 MUSCULOSKELETAL STIFFNESS 5 0.0001
252 DRUG INEFFECTIVE 75 0.0001
253 DEPRESSED MOOD 3 0.0001
254 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
255 HEAD DISCOMFORT 1 0.0001
256 GOUT 1 0.0001
257 CONJUNCTIVITIS 1 0.0001
258 HEPATIC STEATOSIS 1 0.0001
259 NECK PAIN 3 0.0001
260 BACTERIAL INFECTION 1 0.0001
261 HOT FLUSH 4 0.0001
262 BLOOD SODIUM DECREASED 1 0.0001
263 MUSCULOSKELETAL DISORDER 1 0.0001
264 MIGRAINE 5 0.0001
265 EYE IRRITATION 3 0.0001
266 HERNIA 1 0.0001
267 ERUCTATION 1 0.0001
268 EAR PAIN 1 0.0001
269 CHOKING 1 0.0001
270 ORAL HERPES 1 0.0001
271 SKIN FISSURES 1 0.0001
272 ARTHRITIS 4 0.0001
273 DISABILITY 1 0.0001
274 SINUS DISORDER 1 0.0001
275 DISORIENTATION 2 0.0001
276 BLOOD PRESSURE ABNORMAL 1 0.0001
277 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
278 SPINAL FRACTURE 1 0.0000
279 VERTIGO 3 0.0000
280 DISCOMFORT 3 0.0000
281 CHEST PAIN 9 0.0000
282 HYPERSENSITIVITY 9 0.0000
283 DERMATITIS 1 0.0000
284 IMPAIRED WORK ABILITY 1 0.0000
285 IRRITABLE BOWEL SYNDROME 1 0.0000
286 HYPOACUSIS 2 0.0000
287 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
288 LIVER DISORDER 2 0.0000
289 STEVENS-JOHNSON SYNDROME 1 0.0000
290 GLOSSODYNIA 1 0.0000
291 ORAL PAIN 1 0.0000
292 GASTROINTESTINAL DISORDER 4 0.0000
293 CHROMATURIA 1 0.0000
294 INJECTION SITE REACTION 3 0.0000
295 ARTHRALGIA 18 0.0000
296 OROPHARYNGEAL PAIN 4 0.0000
297 PRODUCTIVE COUGH 2 0.0000
298 OVERDOSE 9 0.0000
299 NEURALGIA 1 0.0000
300 CEREBRAL INFARCTION 1 0.0000
301 DYSPEPSIA 4 0.0000
302 DYSGEUSIA 3 0.0000
303 SINUSITIS 4 0.0000
304 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
305 ANAPHYLACTIC SHOCK 1 0.0000
306 SKIN ULCER 1 0.0000
307 RASH GENERALISED 1 0.0000
308 HAEMATOMA 1 0.0000
309 RESPIRATORY TRACT INFECTION 1 0.0000
310 NERVOUSNESS 2 0.0000
311 MUSCULOSKELETAL PAIN 2 0.0000
312 DIZZINESS 19 0.0000
313 ANHEDONIA 1 0.0000
314 DERMATITIS ATOPIC 2 0.0000
315 EAR INFECTION 1 0.0000
316 FEELING ABNORMAL 9 0.0000
317 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
318 FEAR 1 0.0000
319 PAIN OF SKIN 1 0.0000
320 PRODUCT QUALITY ISSUE 5 0.0000
321 MOOD ALTERED 1 0.0000
322 GAIT DISTURBANCE 7 0.0000
323 RESPIRATORY ARREST 1 0.0000
324 ARTHROPATHY 2 0.0000
325 FEELING COLD 1 0.0000
326 BLISTER 2 0.0000
327 SKIN EXFOLIATION 3 0.0000
328 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
329 EYE PAIN 2 0.0000
330 OFF LABEL USE 31 0.0000
331 PAIN IN JAW 1 0.0000
332 FLATULENCE 2 0.0000
333 INTENTIONAL DOSE OMISSION 1 0.0000
334 BACK PAIN 8 0.0000
335 ABDOMINAL PAIN 8 0.0000
336 INTENTIONAL PRODUCT MISUSE 3 0.0000
337 CHILLS 4 0.0000
338 SURGERY 2 0.0000
339 ACUTE MYOCARDIAL INFARCTION 1 0.0000
340 TACHYCARDIA 3 0.0000
341 RESPIRATORY DISORDER 1 0.0000
342 NAUSEA 26 0.0000
343 BLOOD PRESSURE INCREASED 5 0.0000
344 FEELING HOT 2 0.0000
345 FEMUR FRACTURE 1 0.0000
346 NERVOUS SYSTEM DISORDER 1 0.0000
347 DRUG-INDUCED LIVER INJURY 1 0.0000
348 HEAD INJURY 1 0.0000
349 CYSTITIS 1 0.0000
350 PRURITUS 12 0.0000
351 HIP FRACTURE 1 0.0000
352 AMNESIA 2 0.0000
353 PAIN IN EXTREMITY 9 0.0000
354 CHOLELITHIASIS 1 0.0000
355 IMPAIRED HEALING 1 0.0000
356 EYE DISORDER 1 0.0000
357 FUNGAL INFECTION 1 0.0000
358 SYNCOPE 3 0.0000
359 SKIN DISORDER 1 0.0000
360 URINARY RETENTION 1 0.0000
361 DRY SKIN 4 0.0000
362 EYE PRURITUS 1 0.0000
363 FLUSHING 3 0.0000
364 URINARY TRACT INFECTION 5 0.0000
365 PAIN 18 0.0000
366 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
367 GASTRIC DISORDER 1 0.0000
368 HYPERTENSION 6 0.0000
369 LYMPHADENOPATHY 1 0.0000
370 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
371 PLATELET COUNT DECREASED 3 0.0000
372 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
373 PANIC ATTACK 1 0.0000
374 DYSURIA 1 0.0000
375 HEADACHE 17 0.0000
376 BRONCHITIS 2 0.0000
377 DYSARTHRIA 1 0.0000
378 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
379 PALPITATIONS 3 0.0000
380 COUGH 7 0.0000
381 JOINT SWELLING 3 0.0000
382 DRY MOUTH 2 0.0000
383 PSORIATIC ARTHROPATHY 1 0.0000
384 ANXIETY 7 0.0000
385 BLINDNESS 1 0.0000
386 POLLAKIURIA 1 0.0000
387 ROAD TRAFFIC ACCIDENT 1 0.0000
388 URTICARIA 4 0.0000
389 OSTEOARTHRITIS 1 0.0000
390 RENAL FAILURE ACUTE 1 0.0000
391 MYALGIA 4 0.0000
392 RECTAL HAEMORRHAGE 1 0.0000
393 PYREXIA 8 0.0000
394 MENTAL DISORDER 1 0.0000
395 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
396 COVID-19 4 0.0000
397 INSOMNIA 6 0.0000
398 THERAPY NON-RESPONDER 1 0.0000
399 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
400 SKIN IRRITATION 1 0.0000
401 SKIN DISCOLOURATION 1 0.0000
402 OCULAR HYPERAEMIA 1 0.0000
403 NEUROPATHY PERIPHERAL 2 0.0000
404 DISEASE RECURRENCE 1 0.0000
405 RASH ERYTHEMATOUS 1 0.0000
406 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
407 INFECTION 3 0.0000
408 MALAISE 9 0.0000
409 HEART RATE INCREASED 2 0.0000
410 DRY EYE 1 0.0000
411 FLUID RETENTION 1 0.0000
412 CHEST DISCOMFORT 2 0.0000
413 ERYTHEMA 4 0.0000
414 ABDOMINAL DISTENSION 2 0.0000
415 VOMITING 9 0.0000
416 ECZEMA 1 0.0000
417 PARAESTHESIA 3 0.0000
418 DIARRHOEA 12 0.0000
419 DISTURBANCE IN ATTENTION 1 0.0000
420 PNEUMONIA 6 0.0000
421 RASH PRURITIC 1 0.0000
422 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
423 RASH 8 0.0000
424 HAEMATOCHEZIA 1 0.0000
425 ANAPHYLACTIC REACTION 1 0.0000
426 FALL 6 0.0000
427 FATIGUE 14 0.0000
428 THROMBOCYTOPENIA 2 0.0000
429 WEIGHT INCREASED 4 0.0000
430 LETHARGY 1 0.0000
431 PRODUCT SUBSTITUTION ISSUE 1 0.0000
432 BONE PAIN 1 0.0000
433 NASAL CONGESTION 1 0.0000
434 CATARACT 1 0.0000
435 IRRITABILITY 1 0.0000
436 NASOPHARYNGITIS 3 0.0000
437 VISUAL IMPAIRMENT 2 0.0000
438 ASTHENIA 6 0.0000
439 LOSS OF CONSCIOUSNESS 2 0.0000
440 INTENTIONAL OVERDOSE 1 0.0000
441 HYPERHIDROSIS 2 0.0000
442 RHINORRHOEA 1 0.0000
443 PRODUCT DOSE OMISSION 1 0.0000
444 BLOOD CREATININE INCREASED 1 0.0000
445 PSORIASIS 2 0.0000
446 INFUSION RELATED REACTION 1 0.0000
447 DEHYDRATION 2 0.0000
448 VISION BLURRED 2 0.0000
449 MEMORY IMPAIRMENT 2 0.0000
450 SLEEP DISORDER 1 0.0000
451 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
452 THERAPY INTERRUPTED 1 0.0000
453 AGITATION 1 0.0000
454 EPISTAXIS 1 0.0000
455 HYPOAESTHESIA 2 0.0000
456 CHRONIC KIDNEY DISEASE 1 0.0000
457 CONDITION AGGRAVATED 4 0.0000
458 DIABETES MELLITUS 1 0.0000
459 DECREASED APPETITE 3 0.0000
460 INJECTION SITE HAEMORRHAGE 1 0.0000
461 DRUG DEPENDENCE 2 0.0000
462 THROMBOSIS 1 0.0000
463 CONFUSIONAL STATE 2 0.0000
464 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
465 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
466 BALANCE DISORDER 1 0.0000
467 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
468 DEVICE ISSUE 1 0.0000
469 NO ADVERSE EVENT 2 0.0000
470 ADVERSE EVENT 1 0.0000
471 WEIGHT DECREASED 3 0.0000
472 CARDIAC DISORDER 1 0.0000
473 SWELLING 1 0.0000
474 PRODUCT USE ISSUE 2 0.0000
475 CONTUSION 1 0.0000
476 PRODUCT DOSE OMISSION ISSUE 3 0.0000
477 ALOPECIA 2 0.0000
478 SOMNOLENCE 2 0.0000
479 INJECTION SITE PAIN 3 0.0000
480 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
481 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
482 HAEMORRHAGE 1 0.0000
483 CONSTIPATION 2 0.0000
484 DYSPNOEA 5 0.0000
485 RHEUMATOID ARTHRITIS 1 0.0000
486 DEPRESSION 2 0.0000
487 SEIZURE 1 0.0000
488 EMOTIONAL DISTRESS 1 0.0000
489 OEDEMA PERIPHERAL 1 0.0000
490 INJECTION SITE ERYTHEMA 1 0.0000
491 DEATH 6 0.0000
492 PERIPHERAL SWELLING 1 0.0000
493 DRUG INTERACTION 1 0.0000
494 TREMOR 1 0.0000
495 TOXICITY TO VARIOUS AGENTS 1 0.0000
496 CEREBROVASCULAR ACCIDENT 1 0.0000
497 MUSCLE SPASMS 1 0.0000
498 ANAEMIA 1 0.0000